I+Med logo

I+Med

Manufacture and development of biomedical solutions. Specialists in controlled release and smart nanohydrogels.

118 employees · est. 2013 · Spain

VS
LIDDS  logo

LIDDS

LIDDS is a Swedish drug delivery company based on the proprietary technology NanoZolid®

2 employees · est. 2003 · Uppsala, Sweden

LIDDS is the older company (2013 vs 2003); I+Med is the larger of the two.

Side-by-Side Comparison

I+Med LIDDS
Founded
2013 2003 older
Headquarters
Spain Uppsala, Sweden
Employees
118 larger 2
Industry
Not tracked yet Biotechnology, Health Care
Funding Stage
Grant Convertible Note
Total Funding
$71.43K $40.80M
Funding Rounds
1 1
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Nanohydrogels, Controlled Drug Delivery, Biomedical Engineering, Biotechnology Solutions, Nanotechnology, Drug Release Systems, Regulatory Services, Innovation, Customized Products, Molecular Transportation Swedish Company, Drug Delivery, NanoZolid® Technology, Formulation Of Drugs, Local Administration, Controlled Release, Sustained Release, Pharmaceutical Technology, Biomedical Innovation
Website
imasmed.com liddspharma.com
I+Med logo

About I+Med

I+Med is a pharmaceutical laboratory and manufacturer specializing in the development of biomedical solutions, particularly in the area of controlled release and smart nanohydrogels. Founded in 2013 and headquartered in Spain, the company has positioned itself as a world-leading cooperative in the a...

LIDDS  logo

About LIDDS

LIDDS LIDDS is a Swedish drug delivery company based on the proprietary technology NanoZolid®. With NanoZolid®, LIDDS can formulate drugs for local administration, with a maintained and controlled release for up to six months. Founded in 2003, the company operates in the Biotechnology and Health Ca...

We will tell you when either one moves

BounceWatch watches I+Med and LIDDS for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at I+Med and LIDDS — by email.

Frequently Asked Questions

I+Med — Manufacture and development of biomedical solutions. Specialists in controlled release and smart nanohydrogels.. LIDDS — LIDDS is a Swedish drug delivery company based on the proprietary technology NanoZolid®. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
I+Med has raised $71.43K while LIDDS has raised $40.80M.
I+Med and LIDDS operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare I+Med with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at I+Med on 11 Sep 2024, and LIDDS on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy